Advances in breast imaging over the last 15 years have improved early breast cancer detection and management. After treatment for breast cancer, many women choose to have reconstructive surgery. In addition, with the availability of widespread genetic screening for breast cancer, an increasing number of women are choosing prophylactic mastectomies and subsequent breast reconstruction. The purpose of this pictorial essay is to present the spectrum of imaging findings in the reconstructed breast.
Introduction
Breast reconstruction is an important component of breast cancer treatment. Although breast conservation is suitable for many breast cancer patients, some women are recommended to have or choose to undergo mastectomies either for oncologic reasons or to avoid the anxiety associated with regular surveillance. High satisfaction rates have been reported in women after breast reconstruction [1, 2] . The refinement of surgical techniques for breast reconstruction has led to improved outcomes and may influence a patient's decision to undergo a mastectomy instead of breast conservation surgery [3, 4] . For example, the development of the skin sparing mastectomy (SSM) has revolutionized autologous breast reconstruction, and an excellent cosmetic result can be achieved because of the preservation of the native breast skin, which remains after the mastectomy (Figure 1 ). This technique allows for the maintenance of the crucial anatomic borders of the breast and, therefore, has transformed breast reconstruction into a ''filling'' procedure rather than a more complicated ''shaping'' procedure [2e4] . Surgical techniques for breast reconstruction can be divided into 3 groups: (1) implant-based techniques; (2) autologous tissue-based techniques; and (3) a combination of these 2 techniques.
Implant-based breast surgery has been available since the early 1960s when Cronin and Gerow, 2 plastic surgeons from Texas, developed the first silicone gel prosthesis [4] . Modern implant-based breast reconstruction is usually a 2-stage process whereby, at the time of a mastectomy, a tissue expander is inserted under the chest-wall muscle to create a space for the final implant. The tissue expander is like a balloon and is filled, through transcutaneous punctures, with saline solution during follow-up clinic visits. Once the insufflations have created the required space underneath the chest-wall muscle, a final implant (often silicone filled) is used to replace the tissue expander during a second operation. This is usually performed 3-6 months after the initial operation. More recent advances in breast reconstruction have potentially minimized the need for numerous operations. By using an allogeneic dermal substitute (Allo-Derm, Lifecell Corporation, Branchburg, NJ) to help cover the implant, placement of the final implant can be performed during the initial operation and the need for a tissue expander may be omitted. The use of allogeneic dermal substitutes is fairly new within the field of breast reconstruction, and studies looking at outcomes are still in progress at our Canadian tertiary hospital.
Over the last 10 years, autologous breast reconstruction has also seen many advances. Autologous reconstruction techniques commonly include abdominal-based flaps, such as pedicled or free transverse rectus abdominus myocutaneous (TRAM) flaps, muscle sparing free TRAM flaps, deep inferior epigastric perforator (DIEP) flaps, and superficial inferior epigastric artery flaps. In addition, a variety of free flaps from distant donor sites exist, including superior gluteal artery perforator flaps and transverse upper gracilis flaps. Latissimus dorsi flaps may also be used and generally require the additional use of an implant.
Since the 1980s, TRAM flaps have commonly been used for breast reconstruction. Free TRAM flaps that use the deep inferior epigastric vessels have better perfusion compared with traditional pedicled TRAM flaps that use the deep superior epigastric vessels. Therefore, free TRAM flaps potentially have greater application in patients with increased risk of complications, delayed wound healing, and partial flap loss, such as those who smoke and those women who are obese as well as patients who need adjuvant radiotherapy for local or regional control of breast cancer [4] [5] [6] [7] . However, abdominalbased muscle sparing or muscle-preserving perforator (eg, DIEP) flaps are becoming the criterion standard for autologous breast reconstruction against which all forms of breast reconstruction are measured in terms of safety and esthetic outcome [1, 2, 5] . Donor-site preserving flap harvesting techniques have been developed through an enhanced appreciation of flap anatomy and physiology ( Figure 2) .
A variety of breast reconstruction options exist after a mastectomy. Along with advances in reconstructive options, a variety of new modalities exist for breast imaging. The purpose of this review is to describe the mammographic, sonographic, computed tomography (CT), and magnetic resonance imaging (MRI) features in normal and abnormal imaging examinations of reconstructed breasts.
Normal Imaging Features of a Reconstructed Breast
Several breast implant styles are typically offered for most implant types by each manufacturer. An implant ''style'' is typically characterized by a unique combination of basic implant features, such as shape, shell, profile, and fixation. Each style is usually offered in a range of sizes that may vary from 70 mL to more than 1000 mL. Availability of special order and custom implants further increases the number of possible variations. A reconstructed breast with either silicone or saline solution implants presents with a high mammographic density ( Figure 3 ) if a dedicated technique to evaluate exclusively the implant is not used. Silicone implants are more radiodense than saline solution implants. Most saline solutione and dextran-filled implants are inflated through a valve at the time of surgery. The valve is not usually evident on screen film mammography if an overpenetrated image is not obtained, however, the valve can be easily identified in full-field digital mammography (FFDM) by narrowing the window on a digital workstation. In addition to the simple single-lumen dextran-and saline solution-filled implants, all tissue expanders have a valve, some of which have more than 1 lumen. They have been manufactured in a wide variety of shapes and sizes. Radiologists rarely see tissue expanders in the course of breast implant evaluation, because they are intended to be temporary devices and do not require straightforward imaging evaluation. 6 ). On CT or MRI, a thin curvilinear line that parallels the breast contour is sometimes seen, which represents the epithelial layer of the lower abdominal tissue. The radiographic density or signal intensity of attenuation of the fat anterior to the epithelial layer represents the adipose tissue of the native chest wall, whereas the tissue deep to it represents the transposed abdominal wall fat [10, 11] .
A combination of implants and autologous tissue may be used for cosmetic reasons. The imaging appearance of an autogenous myocutaneous flap plus implant is similar to that of a TRAM flap in a reconstructed breast after mastectomy (Figure 7 ).
Benign Imaging Features of a Reconstructed Breast
A frequent complication after autologous breast reconstruction is the presence of fat necrosis. Fat necrosis refers to an area of firmness within adipose tissue that occurs after fat has become devitalized. Although several theories exist, the exact pathophysiology that leads to the formation of fat necrosis has not yet been elucidated. Regardless of the cause, these firm areas can alter the aesthetic result of the breast and can be painful to the patient. Current literature reports a wide range in the incidence of fat necrosis that varies, depending on the type of reconstruction performed (12%e35% for a pedicled TRAM, 5.9%e12.9% for a free TRAM, and 6%e62.5% for a DIEP flap) [6, 7, 12, 13] .
It is important to be able to differentiate fat necrosis from other more worrisome findings within the reconstructed breast. Fat necrosis is often palpable, however, the differential diagnosis of a palpable nodule within the reconstructed breast and/or local changes in the skin adjacent to the mastectomy site includes fat necrosis, scar tissue, oedema, fibrocystic disease, seroma, hematoma, suture or dermal calcifications, abscess, and, more concerning, new or recurrent breast cancer. On mammographic examination (Figures 8e10), fat necrosis can present in a variety of different ways, including a radiolucent mass with a thin wall or with peripheral calcifications (oil cyst), an irregular area of softtissue density, a spiculated mass, and pleomorphic microcalcifications or macrocalcifications [8, 9] . Not surprisingly, fat necrosis is usually located peripherally where the blood supply is deficient.
On sonographic examination, fat necrosis can appear as circumscribed anechoic nodules ( Figure 11 ) with or without posterior acoustic enhancement; however, fat necrosis may also present with a sonographic appearance similar to complex cysts (Figure 12 ), solid mass lesions with ill-defined margins, or solid mass lesions with well-circumscribed margins [9] . Because fat necrosis is often palpable and manifests as a firm mass on physical examination, a targeted ultrasound is often the best approach to provide guidance for image-guided biopsy.
Various MRI features of fat necrosis (Figures 13e16) have also been described. These include a solid irregular mass, with or without a central area of fat intensity, and with enhancement confined to the extreme periphery of the lesion or with intense solid-appearing enhancement that simulates the appearance of tumour recurrence on fat-suppressed images [9] . For this reason, good quality nonenhanced MRI T1-weighted images without fat saturation ( Figure 16 ) are crucial to identify the presence of the central fat signal intensity. This key finding allows one to differentiate fat necrosis from tumour recurrence, because breast cancers do not contain central fat.
Imaging Features of a Recurrent Cancer in a Reconstructed Breast
The residual breast tissue that remains after a skin-sparing mastectomy or modified radical mastectomy has the potential for cancer recurrence. It is generally accepted that all breast tissue cannot be excised completely by a mastectomy because the tissue is distributed over the anterolateral portion of the chest wall and axilla [14] . In 1940, Hicken demonstrated why most mastectomies result in the incomplete removal of the breast tissue and how breast tissue is spread over the anterior chest wall. He injected the lactiferous ducts of 17 breasts that had been excised during a mastectomy to obtain a ''contrast mammogram.'' A total of 95% of the images produced showed ducts passing into the axillary fossa, 15% had extension downward into the epigastric space, and 2% of the ducts extended beyond the limits of the latissimus dorsi muscle. In 2 patients, the ducts coursed across the mid sternal line to the opposite side, although there was no anastomotic communication noted between the 2 sides [14] .
Ongoing surveillance is important to assess for recurrence after treatment for breast cancer. Routine clinical breast examinations are recommended for all patients who have previously had breast cancer. Clinical manifestations of recurrence may range from palpable nodules to mild skin thickening or true ''peau d'orange,'' with or without associated cutaneous erythema.
The use of screening mammography for reconstructed breasts is still controversial [3, 15] . In some institutions, this procedure is not the standard of care, and, in others, it is routine for all patients who have skin-sparing mastectomy. The mammographic presence of a new mass lesion (Figures 17-20) or malignant-appearing microcalcifications in a reconstructed breast is highly suggestive of a recurrent disease. Helvie et al [15] noted that the mammographic appearance of recurrent carcinoma in TRAM flaps is similar to that of primary breast cancer.
The ultrasonographic appearance of many recurrences is also similar to those of primary breast cancer (Figures 19, 20 , 22, 23). However, some recurrences show a sonographic appearance typical of benign lesions, including fat necrosis ( Figure 18 ) and postoperative fluid collection [9] . Ultrasoundguided fine-needle biopsy is often a useful method to obtain samples to prove the pathology diagnosis of a recurrent breast cancer [9, 14, 15] .
The use of CT for the specific evaluation of recurrence after TRAM flap reconstruction has also been addressed in the literature. The thin band that extends to the skin surface on CT represents the transition from full-thickness TRAM flap skin to the de-epithelialized skin that is tunneled under the native chest-wall skin and subcutaneous tissue. Although this band may appear thick within a month of surgery, persistent thickening or the development of new thickening should raise suspicion for infection, inflammation, or recurrent breast cancer [10] . However, this is a rare finding, and routine follow up by CT is not recommended. When a soft-tissue mass is identified on CT within the reconstructed breast (Figures 17,  21, 23) , recurrent breast cancer should be strongly suspected, and mammography and possibly ultrasonography should be recommended.
Breast cancer recurrence after TRAM flap reconstruction is relatively rare. The prevalence ranges from 6.7%e10.6% [14] . Recurrence may occur locally within the reconstructed breast or in regional lymph nodes. MRI has been reported to be useful in the evaluation of autogenous tissue flaps because of its superior resolution of soft-tissue areas [11, 14] . On MRI, tumour recurrence after mastectomy with reconstruction has been described as a mass with low signal intensity on T1-weighted images, intermediate signal intensity on T2-weighted images, and avid and rapid enhancement after administration of gadolinium contrast material [11] . The presence of other features, such as rim enhancement and spiculated margins (Figure 22 ), increases the likelihood of malignancy. Imaging surveillance MRI should be recommended primarily for patients at high risk for developing a recurrence [16, 17] , including patients who have had multifocal in situ duct carcinoma or multifocal and/or multicentric any type of invasive breast cancers and high-risk patients (BRCA mutation carriers, for example).
The use of MRI in reconstructed autologous flaps in asymptomatic patients has not been studied. Scaranelo et al [4] analysed breast implant rupture in a cohort of asymptomatic patients and did not find recurrent breast cancer in the group of patients with a silicone implant included to restore the breast removed after mastectomy. However, this was not the intent of that prospective evaluation. Current review of our series suggests that MRI may allow differentiation of benign from malignant findings in patients after breast reconstruction with a TRAM flap.
In conclusion, breast reconstruction by using autologous flaps has increased in popularity. Mammography, ultrasonography, CT, and MRI facilitate the visualization of normal and abnormal findings of the various types of breast reconstruction methods, including implants, autologous flaps, or a combination of both. Although these imaging modalities are available for the evaluation of the reconstructed breasts, there is no optimal imaging protocol that is recommended for monitoring the reconstructed breast. Therefore, knowledge of the spectrum of normal or abnormal imaging features is required by radiologists. Figure 22 . Images taken 3 years after surgery of a woman who underwent a right mastectomy for extensive invasive lobular carcinoma, followed by reconstruction with a silicone implant. Screening surveillance with breast magnetic resonance imaging, showing an irregular enhancing mass with spiculated margins. Axial postcontrast subtracted images (A) and reconstructed images in the sagittal plane (B), showing the close relation of the recurrent cancer with the breast implant. Digital mammography was not able to demonstrate the mass lesion (C). Ultrasonography was used, and an irregular hypoechoic mass with a surrounding echogenic rim was identified (D). An ultrasound-guided biopsy was performed to prove local recurrence.
